The application and functional mechanism of Chinese herbal medicines in the treatment of chronic hepatitis B

被引:0
作者
Zhang, Jiao [1 ]
Ma, Junrui [2 ]
Dai, Hongyang [1 ]
Zhang, Hushan [1 ]
机构
[1] Zhaotong Hlth Vocat Coll, Zhaotong 657000, Yunnan, Peoples R China
[2] Yunnan Univ Tradit Chinese Med, Sch Nursing, Kunming 650022, Yunnan, Peoples R China
关键词
active compounds; chronic hepatitis B (CHB); Hepatitis B virus (HBV); mechanism; traditional Chinese medicine (TCM); LIVER FIBROSIS; VIRUS; PROLIFERATION; INJECTION; APOPTOSIS; ENTRY;
D O I
10.1080/17460794.2024.2388479
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis B, caused by the hepatitis B Virus (HBV), is an inflammatory liver disease that poses a significant threat to public health. HBV, a hepatotropic DNA virus, can cause chronic and acute Hepatitis B and persistent infection may cause serious complications like cirrhosis, liver cancer, and liver failure. Though nucleos(t)ide analogues (NAs) is the first-line drug for chronic hepatitis B (CHB), they still have several drawbacks such as drug resistance, and low-level viremia. Recent studies suggest that traditional Chinese medicine (TCM) and its active ingredients can inhibit HBV activity and replication, indicating their potentials for CHB treatment. This article focuses on the anti HBV activity and mechanism of TCM, aiming to help develop new anti-HBV drugs and improve the cure rate of CHB.
引用
收藏
页码:325 / 338
页数:14
相关论文
共 85 条
  • [1] The Anti-inflammatory Effects of Isoflavonoids from Radix Astragali in Hepatoprotective Potential against LPS/D-gal-induced Acute Liver Injury
    Aobulikasimu, Nuerbiye
    Zheng, Dan
    Guan, Peipei
    Xu, Lixiao
    Liu, Bo
    Li, Minglei
    Huang, Xueshi
    Han, Li
    [J]. PLANTA MEDICA, 2023, 89 (04) : 385 - 396
  • [2] Phytochemistry and pharmacological activity of the genus artemisia
    Bisht, Dheeraj
    Kumar, Deepak
    Kumar, Dharmendra
    Dua, Kamal
    Chellappan, Dinesh Kumar
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (05) : 439 - 474
  • [3] Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis
    Cai, Fei-Fei
    Bian, Yan-Qin
    Wu, Rong
    Sun, Yang
    Chen, Xiao-Le
    Yang, Meng-Die
    Zhang, Qian-ru
    Hu, Yuanjia
    Sun, Ming-Yu
    Su, Shi-Bing
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [4] Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
    Cai, Fei-Fei
    Wu, Rong
    Song, Ya-Nan
    Xiong, Ai-Zhen
    Chen, Xiao-Le
    Yang, Meng-Die
    Yang, Li
    Hu, Yuanjia
    Sun, Ming-Yu
    Su, Shi-Bing
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [5] Chen C, 2000, J VIRAL HEPATITIS, V7, P225
  • [6] Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats
    Chen, MH
    Chen, JC
    Tsai, CC
    Wang, WC
    Chang, DC
    Lin, CC
    Hsieh, HY
    [J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2004, 32 (02): : 195 - 207
  • [7] Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways
    Chen, Qingshan
    Zhang, Hai
    Cao, Yan
    Li, Ying
    Sun, Sen
    Zhang, Junping
    Zhang, Guoqing
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2179 - 2191
  • [8] Chinese herbal medicine reduces acute hepatitis exacerbation in patients with hepatitis B virus infection: A case-control study in Taiwan
    Chen, Wan-Ling
    Lin, Ching-Heng
    Huang, Chun-Che
    Tsai, Chia-, I
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 42 : 248 - 254
  • [9] Chen Z.-L., 2023, Precis. Med. Res., V5, P15, DOI [10.53388/pmr20230015, DOI 10.53388/PMR20230015]
  • [10] Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine
    Chen, Zhejie
    Liu, Lijuan
    Gao, Caifang
    Chen, Weijie
    Vong, Chi Teng
    Yao, Peifen
    Yang, Yuhan
    Li, Xiuzhu
    Tang, Xudong
    Wang, Shengpeng
    Wang, Yitao
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2020, 258